Learn More
Apexbio Technology LLC Tasisulam 519055-62-0 10mg

Supplier: Apexbio Technology LLC B142210
Tasisulam (CAS 519055-62-0) is a small-molecule anticancer agent that induces apoptosis and modulates tumor vasculature Its activity involves generation of reactive oxygen species reduction of mitochondrial membrane potential G2-M phase arrest and inhibition of angiogenesis via growth factor pathways In vitro Tasisulam inhibits proliferation induces apoptosis and promotes differentiation in hematopoietic cancer cell lines In endothelial cells it suppresses angiogenesis mediated by EGF VEGF and FGF pathways In xenograft models it causes tumor growth inhibition G2-M arrest apoptosis and vascular modulation These properties highlight its potential in oncology research particularly for studies on apoptosis and tumor vascular regulation
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.